Physician
Southern Coast Pain Specialists
Southern Coast Pain Specialists was paid $473K by Medicaid between Mar 2018 and Jan 2020, across 25 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 28% of everything it billed.
33Billing provider infoSOUTHERN COAST PAIN SPECIALISTS
BEAUFORT, SC 29902
BEAUFORT, SC 29902
33aNPI1336653708assigned 11/21/2017
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$473K
24GClaims15,887
24DCodes billed25
24AFirst – last monthMar 2018 – Jan 2020
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in South Carolina
Rank by total paid#5 of 25
Median peer was paid$41K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,769 | $140K | |
| 2019 | 10,104 | $332K | |
| 2020 | 14 | $684.43 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 28% | 3,038 | 2,784 | $132K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 1,872 | 1,726 | $92K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 1,957 | 1,812 | $62K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 8.0% | 609 | 587 | $38K |
| 99205 | Prolong outpt/office vis | 7.9% | 396 | 348 | $37K |
| 62323 | 6.1% | 279 | 210 | $29K | |
| 99152 | 4.0% | 1,437 | 1,059 | $19K | |
| 64493 | 2.3% | 168 | 122 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 156 | 144 | $10K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 1.4% | 867 | 664 | $7K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 76 | 65 | $6K |
| 64483 | 1.1% | 43 | 37 | $5K |
13 more codes
| 64494 | <1% | 146 | $5K | |
| 80305 | <1% | 498 | $4K | |
| 64495 | <1% | 106 | $4K | |
| 77002 | <1% | 111 | $4K | |
| A4550 | Surgical trays | <1% | 854 | $3K |
| 20610 | <1% | 77 | $3K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 439 | $2K |
| J3490 | Unclassified drugs | <1% | 118 | $515.22 |
| 99406 | <1% | 77 | $417.70 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 881 | $190.55 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,548 | $132.17 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 121 | $0.00 |
| 96127 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHUYLER, WALTER (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Southern Coast Spine and Pain Specialists LLC | Beaufort, SC | $618K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.